当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析 - 现金流量表

皓元医药

(688131)

  

流通市值:198.14亿  总市值:198.14亿
流通股本:2.13亿   总股本:2.13亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,608,808,684.46766,432,277.892,931,609,957.751,995,462,290.69
  收到的税费返还24,402,770.6821,537,732.4955,684,412.8247,636,291.12
  收到其他与经营活动有关的现金34,046,113.8414,396,505.666,746,383.3553,081,290.48
  经营活动现金流入小计1,667,257,568.98802,366,515.983,054,040,753.922,096,179,872.29
  购买商品、接受劳务支付的现金752,860,295.43386,443,763.691,358,965,071.12960,999,728.75
  支付给职工以及为职工支付的现金556,872,337.52247,614,825.91929,006,714.17686,018,543.35
  支付的各项税费140,178,270.2953,917,909.03221,394,364.28176,617,051.42
  支付其他与经营活动有关的现金140,282,064.2877,818,719.79226,925,574.73177,965,154.83
  经营活动现金流出小计1,590,192,967.52765,795,218.422,736,291,724.32,001,600,478.35
  经营活动产生的现金流量净额77,064,601.4636,571,297.56317,749,029.6294,579,393.94
二、投资活动产生的现金流量:
  收回投资收到的现金2,355,000,0001,544,000,0004,524,000,0003,293,000,000
  取得投资收益收到的现金2,918,829.281,479,331.7811,989,862.727,635,882.07
  处置固定资产、无形资产和其他长期资产收回的现金净额1,841,581.131,157,917.11,921,258.672,306,477.59
  收到的其他与投资活动有关的现金--16,356.08-
  投资活动现金流入小计2,359,760,410.411,546,637,248.884,537,927,477.473,302,942,359.66
  购建固定资产、无形资产和其他长期资产支付的现金84,142,766.6638,094,205.48221,785,175.99175,041,970.95
  投资支付的现金2,364,548,4961,248,500,0004,462,000,0002,904,500,000
  取得子公司及其他营业单位支付的现金-7,200,00056,185,133.93-
  投资活动现金流出小计2,448,691,262.661,293,794,205.484,739,970,309.923,079,541,970.95
  投资活动产生的现金流量净额-88,930,852.25252,843,043.4-202,042,832.45223,400,388.71
三、筹资活动产生的现金流量:
  吸收投资收到的现金24,168,561.0313,675,350.0457,531,626.857,457,667.6
  其中:子公司吸收少数股东投资收到的现金--20,000,000-
  取得借款收到的现金623,580,397.55346,968,221.44897,532,199.32643,547,451.5
  收到其他与筹资活动有关的现金---16,356.08
  筹资活动现金流入小计647,748,958.58360,643,571.48955,063,826.12701,021,475.18
  偿还债务支付的现金481,234,955.03231,801,105.35631,614,161.21407,312,860.5
  分配股利、利润或偿付利息支付的现金14,655,579.277,360,268.7278,024,134.5452,999,935.81
  支付其他与筹资活动有关的现金34,442,617.1315,905,378.3568,423,458.1236,972,541.64
  筹资活动现金流出小计530,333,151.43255,066,752.42778,061,753.87497,285,337.95
  筹资活动产生的现金流量净额117,415,807.15105,576,819.06177,002,072.25203,736,137.23
四、汇率变动对现金及现金等价物的影响-49,104,530.46-17,323,622.87-1,083,949.138,282,087.85
五、现金及现金等价物净增加额56,445,025.9377,667,537.15291,624,320.29529,998,007.73
  加:期初现金及现金等价物余额1,164,719,993.021,164,719,993.02873,095,672.73873,095,672.73
  期末现金及现金等价物余额1,221,165,018.921,542,387,530.171,164,719,993.021,403,093,680.46
补充资料:
  净利润162,095,918.23-231,645,431.33-
  资产减值准备79,886,893.93-134,087,756.31-
  固定资产和投资性房地产折旧59,673,966.37-109,405,023.63-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧59,673,966.37-109,405,023.63-
  无形资产摊销7,304,533.97-10,507,285.73-
  长期待摊费用摊销18,649,791.08-36,425,102.07-
  处置固定资产、无形资产和其他长期资产的损失-293,523.27--793,500.41-
  固定资产报废损失--19,237,868.94-
  公允价值变动损失-282,760.38--73,589.04-
  财务费用75,206,760.76-68,987,706.33-
  投资损失-311,085.31-15,966,771.96-
  递延所得税-29,541,690.15--49,803,236.17-
  其中:递延所得税资产减少-30,316,380.42--56,500,313.67-
    递延所得税负债增加774,690.27-6,697,077.5-
  存货的减少-269,236,796.53--327,491,978.62-
  经营性应收项目的减少-157,993,515.5--149,351,771.85-
  经营性应付项目的增加72,511,694.16-124,143,103.2-
  其他17,935,928.31-24,196,548.27-
  现金的期末余额1,221,165,018.92-1,164,719,993.02-
  减:现金的期初余额1,164,719,993.02-873,095,672.73-
  现金及现金等价物的净增加额56,445,025.9-291,624,320.29-
公告日期2026-08-272026-04-302026-04-232025-10-31
审计意见(境内)标准无保留意见
TOP↑